Abstract
Epstein-Barr virus (EBV) is a B cell transforming virus that causes B cell malignancies under conditions of immune suppression. EBV orchestrates B cell transformation through its latent membrane proteins (LMPs) and Epstein-Barr nuclear antigens (EBNAs). We here identify secondary mutations in mouse B cell lymphomas induced by LMP1, to predict and identify key functions of other EBV genes during transformation. We find aberrant activation of early B cell factor 1 (EBF1) to promote transformation of LMP1-expressing B cells by inhibiting their differentiation to plasma cells. EBV EBNA3A phenocopies EBF1 activities in LMP1-expressing B cells, promoting transformation while inhibiting differentiation. In cells expressing LMP1 together with LMP2A, EBNA3A only promotes lymphomagenesis when the EBNA2 target Myc is also overexpressed. Collectively, our data support a model where proproliferative activities of LMP1, LMP2A, and EBNA2 in combination with EBNA3A-mediated inhibition of terminal plasma cell differentiation critically control EBV-mediated B cell lymphomagenesis.
Funder
EC | FP7 | FP7 Ideas: European Research Council
Helmholtz-Gemeinschaft
RCUK | Medical Research Council
Publisher
Proceedings of the National Academy of Sciences
Reference80 articles.
1. Epstein–Barr virus: more than 50 years old and still providing surprises
2. The Immunology of Epstein-Barr Virus–Induced Disease
3. S. H. Swerdlow , S. A. Webber , A. Chadburn , J. A. Ferry , “Post-transplant lymphoproliferative disorders” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, (International Agency for Research on Cancer, ed. 4, 2008), pp. 343–349.
4. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders;Morscio;World J. Transplant.,2016
5. The Latent Membrane Protein 1 (LMP1)
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献